Clinical trials
Phase 2 Lymphoma trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Kyowa Kirin Co., Ltd. | 2 |
| Sanofi | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Incyte Biosciences Japan GK | 1 |
| Pfizer | 1 |
| SecuraBio | 1 |
| SymBio Pharmaceuticals | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 13 |
| Hyperuricemia | 2 |
| Leukemia | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Amyloidosis | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.